• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10621
Device Problem Obstruction of Flow (2423)
Patient Problems Angina (1710); Restenosis (4576)
Event Date 08/09/2021
Event Type  Injury  
Event Description
Same case as pr id# (b)(4).(b)(6) registry.It was reported that unstable angina pectoris and restenosis in right crown stent occurred.In (b)(6) 2020, the subject presented with stable angina and was referred for cardiac catheterization and on the same day, the index procedure was performed.The target lesion 1 was located in the proximal right coronary artery (rca) extending up to distal rca with 80 % stenosis and was 49 mm long with a reference vessel diameter of 3.0 mm.The target lesion 1 was treated with pre-dilatation and placement of 2.75 mm x 28 mm overlapped with 3.00 x 28 mm synergy stents system.Post-dilatation was performed with 0% residual stenosis.Two days later, the subject was discharged on clopidogrel.In (b)(6) 2021, the subject was diagnosed with unstable angina pectoris and hospitalized on the same day for further evaluation and treatment.The subject was also diagnosed with stenosis in right crown stent.Intracoronary angiography, intracoronary drug therapy, internal coronary artery resection, intravascular ultrasound (ivus), percutaneous transluminal coronary angioplasty was performed along with drug balloon dilation (target vessel revascularization - tvr) to treat the event.At the time of reporting the outcome of the event was considered to be recovering and resolving.Three days later, the subject was discharged on clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12808164
MDR Text Key280880282
Report Number2134265-2021-13936
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/12/2022
Device Model Number10621
Device Catalogue Number10621
Device Lot Number0025051379
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/13/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age71 YR
Patient SexMale
-
-